Name | Relationship | Address | Signature | Signature date | CIK |
---|---|---|---|---|---|
Salmasi Allen | Chief Executive Officer, Director | 164 EAST 83RD STREET, NEW YORK | /s/ Allen Salmasi | 2025-08-27 | 0001367633 |
NLabs Inc. | 10%+ Owner | 164 EAST 83RD STREET, NEW YORK | NLabs Inc. By: /s/ Janice K, Smith | 2025-08-27 | 0002025902 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VEEA | Common Stock | Other | $5.24M | +5.24M | +43.12% | $1.00 | 17.4M | Aug 14, 2025 | Direct | F1, F2 |
transaction | VEEA | Common Stock | Other | $5.24M | +5.24M | +32.98% | $1.00 | 21.1M | Aug 14, 2025 | Owned by NLabs, Inc. | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VEEA | Common Warrants | Other | $0 | +5.24M | $0.00 | 5.24M | Aug 14, 2025 | Common Stock | 5.24M | $1.10 | Direct | F3, F4 | |
transaction | VEEA | Common Warrants | Other | $0 | +5.24M | $0.00 | 5.24M | Aug 14, 2025 | Common Stock | 5.24M | $1.10 | Owned by NLabs, Inc. | F3, F4 |
Id | Content |
---|---|
F1 | Shares issued in a public best-efforts offering by the Issuer on the Registration Statement (333-288878) pursuant to Form S-1, which shares were issued at a public offering price of $1.00 per share and associated common warrant, and which warrant has an exercise price of $1.10 (subject to adjustment as provided therein). |
F2 | Consists of shares issued to NLabs Inc., a Delaware corporation, of which is Mr. Salmasi is the CEO and stockholder, pursuant to the above-mentioned offering. Mr. Salmasi disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
F3 | Warrants issued in a public best-efforts offering by the Issuer on the Registration Statement (333-288878) pursuant to Form S-1, which warrants were issued at a public offering price of $1.00 per share and associated common warrant, and which warrant has an exercise price of $1.10 (subject to adjustment as provided therein). |
F4 | Consists of warrants issued to NLabs Inc., a Delaware corporation, of which is Mr. Salmasi is the CEO and stockholder, pursuant to the above-mentioned offering. Mr. Salmasi disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these warrants in this report shall not be deemed an admission of beneficial ownership of all of the reported warrants for purposes of Section 16 or for any other purpose. |